Predictors of right ventricular function and size in patients with hypertrophic cardiomyopathy.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
03 12 2020
03 12 2020
Historique:
received:
15
09
2020
accepted:
17
11
2020
entrez:
4
12
2020
pubmed:
5
12
2020
medline:
18
3
2021
Statut:
epublish
Résumé
We investigated factors associated with right ventricular (RV) function and size in hypertrophic cardiomyopathy (HCM) patients. Two hundred fifty-three consecutive HCM patients and 20 healthy volunteers underwent cardiac magnetic resonance examination. In addition to measuring RV function (ejection fraction-RVEF) and size (end-diastolic volume-RVEDV), each image was inspected for the presence of RV and left ventricular (LV) hypertrophy, and the maximal wall thickness of the left and right ventricles was recorded. HCM patients had higher RVEF and lower RVEDV than healthy volunteers and similar RV mass. The mean RV wall thickness was higher in HCM patients than in controls. LV late gadolinium enhancement (LGE) was present in 89.7% of patients, and RV LGE was present in 3.1% of patients (p < 0.0001). Univariate and multivariable analyses revealed that LVEF, peak LV outflow tract gradient, LV LGE, maximal LV wall thickness, and tricuspid regurgitation (TR) volume by magnetic resonance imaging were positive predictors of RVEF. In addition to TR volume, the only independent predictor of RVEF < 45% was LVEF (odds ratio = 0.80, 95% confidence interval 0.67-0.95). Multivariable analysis revealed that LVEDV and TR volume were positive predictors of RVEDV, whereas negative predictors were RVEF, maximal RV wall thickness, LV LGE, and age. Neither estimated systolic pulmonary artery pressure nor TR grade by echocardiography proved to be predictors of RVEF. There were no differences in either the maximal RV wall thickness or the maximal left ventricular (LV) wall thickness in patients stratified according to NYHA functional class (p = 0.93 and p = 0.15, respectively). There were no differences in mean RV wall thickness in patients categorised based on the number of clinical risk factors for sudden cardiac death (SCD), i.e., non-sustained ventricular tachycardia, family history of SCD, or unexplained syncope (p = 0.79). On the other hand, there was a weak positive association between RV hypertrophy and the estimated probability of SCD at 5 years (rho = 0.16, p = 0.01). RV systolic dysfunction measured as decreased RVEF was uncommon in HCM and was associated with poor LV systolic function. LV also had a significant impact on RV size.
Identifiants
pubmed: 33273702
doi: 10.1038/s41598-020-78245-x
pii: 10.1038/s41598-020-78245-x
pmc: PMC7713380
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
21054Références
Sci Rep. 2020 Feb 6;10(1):1967
pubmed: 32029853
Clin Radiol. 2017 Apr;72(4):286-292
pubmed: 28069158
Radiology. 2012 Oct;265(1):78-86
pubmed: 22771877
Am J Cardiol. 2014 Jan 15;113(2):361-7
pubmed: 24230980
Sci Rep. 2019 Feb 25;9(1):2644
pubmed: 30804397
J Am Coll Cardiol. 2004 Mar 17;43(6):1068-74
pubmed: 15028368
Arch Cardiovasc Dis. 2013 Aug-Sep;106(8-9):440-7
pubmed: 23906680
J Am Soc Echocardiogr. 2010 Jul;23(7):685-713; quiz 786-8
pubmed: 20620859
J Am Soc Echocardiogr. 2017 Apr;30(4):303-371
pubmed: 28314623
Eur Heart J. 2014 Oct 14;35(39):2733-79
pubmed: 25173338
Ann Thorac Surg. 2019 Jan;107(1):e23-e25
pubmed: 29944878
Circulation. 1995 Jul 15;92(2):219-30
pubmed: 7600654
Am J Cardiol. 2019 Aug 15;124(4):604-612
pubmed: 31204037
Eur Heart J Cardiovasc Imaging. 2013 Jul;14(7):611-44
pubmed: 23733442
Am J Physiol. 1991 Nov;261(5 Pt 2):H1514-24
pubmed: 1951739
Hellenic J Cardiol. 2020 Jan - Feb;61(1):3-8
pubmed: 30508591
Circulation. 2006 Nov 21;114(21):2232-9
pubmed: 17088454
Clin Cardiol. 2001 Jan;24(1):2-8
pubmed: 11195601
Pol Arch Med Wewn. 2013;123(10):539-46
pubmed: 23827953
Am J Cardiol. 2009 Feb 1;103(3):420-5
pubmed: 19166701
Am J Cardiol. 2007 Oct 15;100(8):1293-8
pubmed: 17920373
J Am Coll Cardiol. 2002 Dec 4;40(11):2044-52
pubmed: 12475468
J Thorac Cardiovasc Surg. 1994 Jun;107(6):1496-502
pubmed: 8196395
Sci Rep. 2020 Mar 13;10(1):4707
pubmed: 32170130
Int J Cardiol. 2016 Jan 1;202:75-6
pubmed: 26386927
Int J Cardiol. 2012 Feb 9;154(3):259-64
pubmed: 20937536
Int J Cardiol. 2012 Oct 18;160(3):165-70
pubmed: 21570135